JUPITER

Jupiter Bioscience Limited has informed the Exchange that "Jupiter Bioscience Limited is negotiating a multi year supply contract worth Rs.75 Crores for peptide Building Blocks with large Multinational Big Pharma Companies based in Europe".

Jupiter Bioscience Limited has informed the Exchange that the Board of Directors of the Company in their meeting held on December 24, 2010 have proposed and approved the following: (1) The Board of Directors has proposed an Increase in Authorised Share Capital from Rs.70 Crores to Rs.150 Crores; (2) The Board of Directors has proposed Preferential Allotment of Equity Share Warrants/Shares to the Promoter/Associates and others; (3) The Board of Directors have proposed a resolution subject to approval of Share Holders for raising of Fund through Preferential Issue, QIP, FCCB's, ADR's, GDR's, etc

Jupiter Bioscience Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2010.

Jupiter Bioscience Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on October 22, 2010 has concluded the placement of 35,00,000 Global Depository Receipts at US$ 19.50 per Global Depository Receipt (Representing 3,50,00,000 equity shares of Rs. 10/- each) amounting to US$ 68.25 million. Accordingly, the Board has approved and allotted 35,00,000 Global Depository Receipts underlying 3,50,00,000 equity shares of Rs. 10/- each representing the said GDR's.

Jupiter Bioscience Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on July 02, 2010 has concluded the placement of 11,30,000 Global Depository Receipts at US$ 19 per Global Depository Receipt (Representing 1,13,00,000 equity shares of Rs. 10/- each) amounting to US$ 21.47 million. Accordingly, the Board has approved and allotted 11,30,000 Global Depository Receipts underlying 1,13,00,000 equity shares of Rs. 10/- each representing the said GDR's.

Jupiter Bioscience Limited has informed the Exchange that the Annual General Meeting of the Company will be held on August 9, 2010. Further, the Register of Members of the Company will remain closed from August 7, 2010 to August 9, 2010 both days inclusive for ther purpose of AGM and dividend.

Jupiter Bioscience Limited has informed the Exchange that the Board of Directors of the Company in their meeting held on June 30, 2010 have proposed and approved the following: (1) The Board of Directors has proposed an Increase in Authorized Share Capital from Rs.30 Crores to Rs.70 Crores. (2) The Board of Directors has proposed Preferential Allotment of Equity Share Warrants to the Promoter/Associates and others.(3) The Board of Directors have proposed a resolution subject to approval of Share Holders regarding raising of Equity Fund (Preferential Issue, QIP, FCCB's, ADR's, SDR'S, etc.,) to

Jupiter Bioscience Limited has informed the Exchange that the Board of Directors at its meeting held on May 29, 2010 have recommended a dividend of Rs. 2/- per share (20%) for the financial year ended March 31, 2010 subject to approval of members at ensuing Annual General Meeting.